Bridging the dermatologist shortage gap in the United States.Training the Next Generation of Dermatologists < Back Training the Next Generation of Dermatologists Clay J. Cockerell, MD, JD, MBA Aug 28, 2023 Bridging the dermatologist shortage gap in the United States. The physician shortage plaguing our profession across the nation is impacting specialties in every area, and it will soon impact the field of dermatology especially hard. The American Academy of Dermatology estimates a shortage ranging from 3,800 to 13,400 dermatologists in the coming decades. In fact, you are very likely witnessing the effects of this shortage with increased wait times for patients seeking medical care. From 2004 to 2017, the average wait time to see a dermatologist increased 33% (from 24.3 days to 32.3 days). In 2022, the trend continued with an average wait time of 34.5 days. This raises concerns about the future of patient care and creates an urgent need to ensure that we have a consistent pipeline of skilled dermatologists entering the profession. Availability of residency positionsOne reason for the shortage of incoming dermatologists is due in large part to the lack of residency programs. Demand for the specialty remains high, yet finding a dermatological residency program can be difficult. According to the National Resident Matching Program, there were 864 applicants (including both MD and DO applicants) for the 499 dermatology residency positions offered this year. Those who are accepted into dermatology residency programs are traditionally among the most academically accomplished of their peers. As such, it is extremely competitive to be accepted for a dermatology residency training position. More residency training opportunities In my Dallas-based dermatopathology practice, we are working to bridge the gap with a new dermatology residency program offered through The University of North Texas Health Science Center at Fort Worth’s Texas College of Osteopathic Medicine (TCOM). This year, TCOM was ranked as the top medical school in Texas by the U.S. News & World Report. It has also been ranked No. 1 by the publication among osteopathic schools nationwide for two consecutive years. Launching the program amidst a global pandemic was no small feat and is a true testament to the faculty’s commitment to seeing the project across the finish line. The process of setting up the residency program in 2018. It typically takes six months to a year of planning and preparation for the application, followed by two more years for a residency program to receive accreditation from the Accreditation Council for Graduate Medical Education. While COVID-19 slowed the process down even further, our team persevered, and we received initial accreditation for the program on April 21, 2023. Although we did not go through the match process this year, 25 individuals who learned that the program was approved reached out and went through the interview process. We found three excellent candidates who began their training in July. The program is accredited for three positions per year and will ultimately have nine trainees when fully enrolled. Enhanced training for residents There have been many changes in the field of dermatology since I entered the medical profession. We have seen huge advancements in treatments and therapeutic agents, as well as a number of sub-specialties added under the broader dermatology umbrella. At the same time, it is heartening to recognize there are some things that remain the same, such as the reasons that motivate some of these young physicians to pursue the specialty. “I chose dermatology because I love how you can see everything – the disease, the histology and the patient’s improvement,” said resident Ciaran Symthe, DO. “The skin is our interface with the external world, offering a fascinating perspective on health and disease and a rewarding way to improve patients’ psychosocial wellbeing.” The residents in our program can expect to receive a classical style of training that prepares them for this dynamic and ever-changing field, including opportunities to learn about surgery, pathology, pediatric dermatology, cosmetic dermatology and other sub-specialties. “I can’t imagine a better residency program. We have a positive working environment with great clinical and didactic experiences in both private practice and academic settings. We also have numerous opportunities to get involved in dermatology via networking events, industry relationships, research and conferences. What sets our program apart is the positive environment and rockstar attendings, who can open up doors and support/encourage us to be influential contributors to the field of dermatology,” said Dr. Symthe. The residents spend time in the clinic seeing patients as well as at our dermatopathology practice, Cockerell Dermatopathology, where they will analyze many biopsy specimens, including the ones they take from their own patients. “I chose to pursue dermatology because I get a mix of medicine and surgery. In addition to their skin pathologies, many patients suffer from adverse psychosocial issues because of these conditions, so I appreciate the opportunity to treat them holistically,” said resident Susuana Adjei, DO. “This program provides comprehensive training in the field of dermatology, so I know I’ll be prepared for my future. Our faculty is also made up of dermatologists who are very successful in their careers, so I know we’ll be able to learn how to navigate the field well.” In addition, our residents will have the opportunity to attend conferences at the local, regional and national level, as well as receive training on the business, financial and legal aspects of operating a medical practice. “The residency program is laying a strong foundation for my future career in dermatology, aligning seamlessly with my goals of becoming an excellent dermatologist and a leader in the field. Through its comprehensive curriculum, hands-on experiences and exposure to a wide range of pathologies, I'm gaining practical skills and in-depth knowledge essential for success. Furthermore, the mentorship and guidance from my faculty are shaping my clinical approach and facilitating the growth of a robust professional network, said resident Marissa Ceresnie, DO. “What truly sets dermatology apart for me is the ability to profoundly impact people's quality of life by addressing their skin, hair and nail concerns. Beyond combining my affinity for visual diagnosis and performing hands-on procedures, I'm passionate about providing care that not only enhances health but also contributes to overall well-being.” Final thoughts My esteemed colleagues and I are committed to training the next generation of dermatologists to be highly skilled, well-rounded physicians with extensive expertise in the field. We are excited about the outstanding residents we have in our program and take pride in knowing they are part of the solution to ensuring that patients will continue to receive quality dermatological care for years to come. About Clay J. Cockerell, MD, JD, MBA Dr. Clay J. Cockerell is a world-renowned specialist in treating and diagnosing skin disorders and has diagnosed over three million biopsies. An internationally recognized pioneer in his field and double board-certified in dermatology and dermatopathology, Dr. Cockerell has been practicing medicine since 1986. He is currently the Founder & President of Cockerell Dermatopathology and the Program Director of the Health Education Services dermatology residency program sponsored by the Lake Granbury Medical Center. Also, Dr. Cockerell sees patients a few days per month to assist with resident training and to keep his clinicopathological skills sharp. Dr. Cockerell has held numerous leadership positions within several highly regarded medical associations. Most notably, he served as the President, Secretary & Treasurer and a member of the Board of Directors of the American Academy of Dermatology, President of the Texas Dermatological Society, and President of the Dallas Dermatological Society. Also, Dr. Cockerell holds leadership roles as Founder and President of Cockerell Dermatopathology and a former AmeriPath Board of Directors member. Dr. Cockerell and his wife, Brenda, had a lifelong dream of producing wine and, in 2005, purchased a vineyard in Calistoga, California. They now produce wine under the Coquerel Family Wine Estates label. Dr. Cockerel and Brenda have two children, Charles and Lillian, and they have been married for forty-six years. In addition, Dr. Cockerell and Brenda enjoy traveling, golf, and winter sports. About Cockerell Dermatopathology The Cockerell Dermatopathology story begins with Dr. Clay J. Cockerell's vision to establish a practice whose mission is to treat each specimen as if it came from one of own family members. Family! At Cockerell Dermatopathology, every employee is driven by a relentless pursuit of diagnostic excellence. We specialize in evaluating dermatologic disorders, tackling cases ranging from the routine to the most challenging. Our practice continuously invests in cutting-edge technologies to best serve each referring clinician and their patients. These innovations result in higher-quality diagnostic slides, quicker turnaround times for routine cases, and seamless deployment of EMR interfaces. From an educational perspective, Cockerell Dermatopathology is more than a dermatopathology practice. We host numerous in-person and internet-based education events and boast a state-of-the-art 14-headed microscope for dermatology resident training sessions. Our services extend beyond borders, serving hundreds of clinicians in Texas, throughout the United States, and globally. With a highly accessible team of board-certified dermatopathologists and a dedicated support staff, our vision is simple yet profound. Family, we treat every specimen as if it were from one of our own family members. Previous Next

Business 201 Faculty < Back Jeff Libby Partner Jeff Libby is more than an outstanding attorney and counselor; he is a trusted advisor. Jeff's practice focuses on commercial real estate and commercial loan transactions in which he assists clients on a local and national basis in a wide array of development, leasing, lending and construction matters. Mr. Libby works alongside developers of medical office buildings, retail shopping centers, multifamily complexes and single-family lots assisting with site acquisition, due diligence, subdivision and platting, zoning, entitlements and financing, as well as the construction of improvements, leasing, management and asset disposition. Jeff helps landlords and tenants successfully negotiate their commercial lease agreements, and counsels owners and contractors throughout the construction process. Mr. Libby also assists local community banks and national institutional lenders in processing and closing commercial loan transactions. Specialties Include: Commercial Real Estate Transactions Commercial Loan Transactions Commercial Lending Site Acquisition and Disposition Sale-Leaseback Transactions Medical Office Building Development Retail Development Mixed Use Development, Shopping Center Development Office Building Development Multifamily Development Single-Family Development Leasing (Landlord / Tenant) Medical Office Leasing Retail Leasing Shopping Center Leasing Commercial Office Leasing Industrial Leasing Warehouse Leasing Construction (Owner, Contractor, Subcontractor) Entitlements and Zoning Business Loan Transactions (Lender / Borrower) Commercial Mortgage Loans (Lender / Borrower) Title and Survey Easements Covenants, Conditions and Restictions (CCRs) Deed Restrictions Owner Associations Business Transactions Corporate Transactions https://www.libbysparks.com/ Business201 Home

Philip LeBoit, MD < Back Philip LeBoit, MD Faculty Professor of Pathology and Dermatology Division Chief of UCSF Dermatopathology and Oral Pathology Service After training in Anatomic Pathology at the University of California, San Francisco and in Dermatopathology at both New York University (under the late Bernard Ackerman, M.D.) and at New York Hospital-Cornell Medical Center (with N. Scott McNutt, M.D.), Dr. LeBoit founded the UCSF Dermatopathology and Oral Pathology Service in 1987, with the goal of bringing academic expertise to a larger patient base than that of traditional university-based dermatopathology sections. Dr. LeBoit's investigative work includes the delineation of granulomatous slack skin as a lymphoma, the first comprehensive description of bacillary angiomatosis and bacillary peliosis hepatis, the development of the concept of palisaded neutrophilic and granulomatous dermatitis, the application of first morphometric and then molecular studies to melanocytic neoplasms and the initial description of nephrogenic systemic fibrosis. Dr. LeBoit has written over 250 peer reviewed publications, over 25 book chapters, and co-edited the dermatology textbook, Cutaneous Medicine and Surgery. Another major project for the World Health Organization was editing the WHO "blue book" Skin Tumors. Dr. Massi and Dr. LeBoit authored the textbook, Histologic Diagnosis of Nevi and Melanoma, the second edition of which was published in 2014. Dr. LeBoit has given over 400 invited lectures in North and South America, Europe and Asia. Dr. LeBoit served as editor-in-chief of the American Journal of Dermatopathology from 1997-2006, served as an associate editor of the Journal of Investigative Dermatology, and am currently an editor of Seminars in Cutaneous Medicine and Surgery. Dr. LeBoit's service to the International Society of Dermatopathology includes membership on the executive committee and terms as Secretary-Treasurer and as President of the Society (2004-7). Dr. LeBoit have received the Ackerman Award from the International Society of Dermatopathology, and am the only person who has received both the Founders Award and the Pinkus Award from the American Society of Dermatopathology. PS Home

Courtney Schadt, MD Courtney Schadt, MD Faculty Board Certifications: Dermatology Medical Degree: Vanderbilt University School of Medicine Residency: Vanderbilt University Division of Dermatology Internship: Internal Medicine, Vanderbilt University Medical Center Special Areas of Expertise: General Dermatology, Medical Dermatology, Skin Cancer Affiliations: Associate Professor of Medicine, University of Louisville Division of Dermatology PS Winter Home

Stan Tolkachjov, MD Stan Tolkachjov, MD Faculty Dr. Stan Tolkachjov is a double board-certified dermatologist and fellowship-trained Mohs micrographic surgeon with interests in skin cancers, Mohs surgery & complex facial reconstruction , pyoderma gangrenosum , neutrophilic dermatoses, cosmetics, and hair disorders & restoration. He is the Dallas-Fort Worth area Director of Mohs Micrographic & Reconstructive Surgery for Epiphany and has performed over 20,000 cases. He’s the Founder and Director of the ACGME-accredited Micrographic Surgery and Dermatologic Oncology Fellowship and Core Dermatology Residency Faculty at Baylor University Medical Center. He’s a Clinical Assistant Professor of Dermatology at UT Southwestern, Clinical Associate Professor at Texas A&M College of Medicine, and a Staff Dermatologic Surgeon at the Dallas VA Medical Center, serving our veterans. He’s also the current President of the Dallas Dermatological Society. He graduated from Emory University with a degree in Neuroscience and Behavioral Biology where he was on the varsity track and field team and played rugby. He then attended University of Tennessee College of Medicine graduating first in his class of 159 medical students where he was elected to the professionalism committee for 4 years, an AMA representative, president of the Student Surgical Society, and a member of the prestigious Alpha Omega Alpha honor society followed by a rigorous transitional year internship at the Methodist University Hospital at the University of Tennessee with a combined focus on medicine and surgery. He completed his residency at the world-renowned Mayo Clinic in Rochester, Minnesota, at which time it was ranked the #1 hospital in the world by U.S. News & World Report . He did a formal Mohs Micrographic Surgery and Dermatologic Oncology Fellowship at the Surgical Dermatology Group in Birmingham, Alabama, focusing on Mohs surgery and reconstruction, where he also practiced for the first few years of his career. Dr. Tolkachjov’s involvement in education and research/clinical trials has facilitated over 175 publications in major medical journals such as the Journal of the American Academy of Dermatology (JAAD) , Mayo Clinic Proceedings , Dermatologic Surgery , Journal of Investigative Dermatology , British Journal of Dermatology , International Journal of Dermatology , Journal of Drugs in Dermatology , Journal of Oral and Maxillofacial Surgery, Lasers in Surgery and Medicine, Dermatologic Clinics, Anais Brasileiros De Dermatologia, Orphanet Journal of Rare Disorders, and Pediatric Dermatology , amongst others. He has contributed chapters to several books with an international audience and has authored and edited 2 textbooks on Mohs surgery and complex facial reconstructive techniques, which include distinguished international panel of contributing authors. He has also edited 2 editions of Dermatologic Clinics . He continues to teach students, residents, and fellows with various speaking engagements nationally and internationally including venues such as New York, Amsterdam, Manila, Milan, Copenhagen, Manchester, Greece, Moscow, Taiwan, Geneva, Kuala Lumpur, Brazil, Berlin, and Vancouver, amongst others. He was also voted as Teacher of the Year by the dermatology residents at UT Southwestern in Dallas and Physician of the Year by Epiphany Dermatology in 2021. As a leader in the field of dermatology and Mohs surgery, he is an active member, frequent lecturer, and holds committee positions in the: American Academy of Dermatology (AAD) American College of Mohs Surgery (ACMS) American Society of Dermatologic Surgery (ASDS) European Academy of Dermatology and Venereology (EADV) International Society for Dermatologic and Aesthetic Surgery (ISDS) American Society for Laser Medicine & Surgery (ASLMS) California Society of Facial Plastic Surgery (CSFPS) O’Leary Society (Mayo Clinic Dermatology Alumni) European Society for Micrographic Surgery (ESMS) Skin Cancer Outcomes Consortium (SCOUT) Consortium for Harmonizing Outcomes Research in Dermatology (CHORD) Committees on which he has or is currently serving include: Mohs Appropriate Use Criteria (AAD) Mohs Micrographic Surgery Committee (AAD) Dallas Dermatological Society – President World Congress Fund Review Task Force (AAD) Former Chair of the Communications & Public Relations Committee (ACMS) Professional Conduct Committee (ASDS) Awards Work Group (ASDS) Journal Awards Work Group (ASDS) Journal of the AAD (JAAD) Editorial Mentorship Program (AAD) Communications & Public Relations Committee (ACMS) IDEA (innovation/development/evaluation/assessment) panel (AAD) Section of Hospital Dermatology Committee (Mayo Clinic Dept. of Dermatology) O’Leary Society Board of Directors – Mayo Clinic Dermatology Alumni Association Dr. Tolkachjov has done additional training with experts in the aesthetic field for fillers, neurotoxins, KYBELLA®, chemical peels, and lasers. When approaching a cosmetic patient, he strives for a natural and subtle appearance and treats each patient’s unique concerns while obeying anatomical symmetry and complementing the natural features of each individual. With cosmetics, he takes a conservative approach that fits a patient’s desired goals and budget. He’s one of around 50 physicians in the country trained on implantation of SCENESSE® for the treatment of erythropoietic protoporphyria. In his spare time, Dr. Tolkachjov enjoys coaching sports, trivia, travel, and spending time with his wife, two children and dog, Bella. His easygoing demeanor, outgoing personality, and enthusiasm for patient contributes to the welcoming environment of his dedicated team while his meticulous approach and precision allows for the highest cure rates and excellent aesthetic reconstructive outcomes. PS Winter Home

Business 201 Faculty < Back Mary Nix Partner Mary Goodrich Nix is a Partner at LPHS with 25 years of experience handling complex commercial litigation. She frequently handles non-compete and trade secret litigation for publicly traded and privately held companies, including Fortune 500 , middle market companies, and startups in a variety of industries. Ms. Nix has extensive courtroom experience, including multiple jury trials, bench trials and injunction evidentiary hearings. She has arbitrated numerous cases throughout Texas and in other parts of the country. Mary is frequently called upon to assist companies when key employees move between competitors. In her work related to confidential information and trade secret protection, she advises clients in the identification of confidential information, trade secrets and other intellectual property assets and options for protection. Ms. Nix is Board Certified in Labor and Employment Law by the Texas Board of Legal Specialization. She has worked successfully with the U.S. Equal Employment Opportunity Commission (EEOC) , the U.S. Department of Labor (DOL) , the Texas Workforce Commission (TWC) and several other federal, state and local government agencies when a client is the subject of a complaint. Advocacy in this area includes responding to the complaint, negotiating where appropriate and advocating for her clients in administrative hearings. Frequent matters she handles include allegations of breach of contract, breach of fiduciary duty, tortious interference claims, Title VII claims, claims related to discrimination, harassment, retaliation and alleged violations of Americans with Disabilities Act (ADA), Fair Labor Standards Act (FLSA), Family and Medical Leave Act (FMLA), Families First Coronavirus Response Act (FFCRA), Age Discrimination in Employment Act (ADEA), Equal Pay Act (EPA) and alleged Occupational Safety and Health Act (OSHA) violations. https://www.lynnllp.com/ Business201 Home

Douglas Gray, MSOR, MBA < Back Douglas Gray, MSOR, MBA Faculty Douglas A. Gray is an entrepreneur, practitioner, leader, educator, and author with 30+ years of experience in Data & Analytics, IT/Software, E-Commerce, and Consulting. Mr. Gray has worked for Fortune 1-250, start-up, and early-stage companies in industries including retail, airlines, travel distribution, financial services, healthcare insurance, consulting, and commercial software. Mr. Gray is currently a Director, Data Science at Walmart Global Tech – US Omni Retail Tech where he leads teams that increase efficiency, cost effectiveness, and profit performance leveraging data and advanced analytics methods and solutions focused on End-to-End Fulfillment. His teams deliver economic impact and business value in the 9-figure range annually. He has been a member of two INFORMS Prize winning organizations: Walmart (2023) and American Airlines (1990). Previously, Mr. Gray served as Director, Enterprise Data & Analytics at Southwest Airlines. Through the data and analytics solutions delivered, Doug’s organization at Southwest Airlines generated $100M in annual operating cost reduction, and $100M in annual revenue augmentation. As a result, the team was recognized with the following awards: Teradata EPIC Award, FICO Decision Management Innovation Award, Alteryx Best Business ROI Award (2), Drexel LeBow Analytics50 Award (2), and AGIFORS Operations Best Innovation Award. Mr. Gray was a founding team member at award-winning American Airlines Decision Technologies (AADT) (now part of CAE, Inc.), which pioneered numerous innovations driving substantial economic impact in the use of Analytics in the airline industry, solving commercial and operational problems across the enterprise. At Sabre, he served as the founding CTO of Travelocity.com , the world’s first real-time, Internet-based travel reservation system. Mr. Gray served as Acting Director of Analytics at Blue Cross Blue Shield of Kansas City where he led the development of an Analytics Platform, i.e., a data warehouse, an operational dashboard, and a portfolio of analytical scoring models for measuring patient propensity for health conditions, behaviors, and outcomes. BCBSKC evolved the platform into a commercial Analytics-as-a-Service enterprise (CobaltTalon) serving other BCBS entities that was later sold to HealthLumen. Through his own company, Blueprint Technology Advisors, LLC, d.b.a., Optima Analytics, Mr. Gray advises executive leadership teams on best practices of applying Technology & Analytics to corporate strategy and Digital Transformation, and implementing Technology & Analytics organizations and capabilities. Mr. Gray has taught executive education seminars in Analytics since 2009. As an Adjunct Professor at SMU, Mr. Gray taught Business Analytics in the Cox School of Business EMBA Program 2016-20, through which his students’ real-world Case Analysis Projects routinely delivery 6-7-8-figure ($M) tangible, measurable business value and economic impact benefits. Mr. Gray serves as the primary instructor for Business Analytics in SMU’s MS in Data Science program. In 2025, Mr. Gray will offer an elective course, AI Strategy, in SMU’s EMBA Program. Mr. Gray teaches Analytics & AI Strategy for SMU Continuing and Professional Education and SMU Cox Leadership Academy. He currently serves on SMU’s Future of Work Advisory Council. PS Home

Roger Ceilley, MD < Back Roger Ceilley, MD Faculty Dr. Ceilley received his Medical Degree and dermatology residency training at the University of Iowa. He is board-certified in dermatology and dermatopathology and is a fellow of the American College of Mohs Micrographic Surgery and Cutaneous Oncology. He has served as president of the American Academy of Dermatology, president of the American Society for Dermatologic Surgery, and is a diplomat of the American Board of Dermatology. He is the director of our training program in Mohs Surgery and Dermatologic Surgery. Memberships and Awards: Board Certified, American Board of Dermatology Fellow, American Academy of Dermatology Past President, American Academy of Dermatology Past President, American Society for Dermatologic Surgery American Medical Association Director training program in Mohs Surgery and Dermatologic Surgery PS Home

James Del Rosso, DO < Back James Del Rosso, DO Faculty James Q. Del Rosso, D.O. has been practicing dermatology since 1986, and in the Las Vegas area at the Las Vegas Skin & Cancer Clinics since 1997. He is an Adjunct Clinical Professor of Dermatology at the Touro University of College of Osteopathic Medicine in Henderson, Nevada, and has the distinction of being the first and only dermatology residency program director in the history of the state of Nevada. Prior to coming to Las Vegas, Dr. Del Rosso served as Head of the Section of Dermatology at the Ohio University College of Osteopathic Medicine in Athens, and Visiting Faculty Member in Dermatology at Ohio State University (OSU) in Columbus where he twice was honored as Educator of the Year by the dermatology residents and dermatopathology fellows. He received his D.O. degree from Ohio University College of Osteopathic Medicine, interned at Doctors Hospital in Columbus, completed a dermatology residency at Atlantic Skin Disease and Skin Surgery in Fort Lauderdale, Florida, and a fellowship in Mohs micrographic surgery and cutaneous oncology at OSU. At his practice in Henderson, Nevada, he is proud of the quality of service provided and has an exceptional support staff of nurses and medical assistants who are dedicated to quality patient care. Dr. Del Rosso is an internationally renowned dermatologist. He is Clinical Editor of the Journal of Clinical and Aesthetic Dermatology, has published multiple peer-reviewed articles and textbook chapters, and was President of the American Acne & Rosacea Society, American Society of Mohs Surgery, and the American Osteopathic College of Dermatology. He is one of the most highly requested and well-respected educators in dermatology, invited to present regularly at dermatology meetings both nationally and internationally. Dr. Del Rosso has many outside interests, especially music, and stays busy at times with four children and six grandchildren. PS Home

Brian Berman, MD, PhD < Back Brian Berman, MD, PhD Faculty Professor Emeritus of Dermatology and Cutaneous Surgery University of Miami Miller School of Medicine, Miami, FL Co-Director Center for Clinical and Cosmetic Research Skin and Cancer Associates, Aventura, FL Senior Scientific Advisor and Acting Chief Medical OfficerBerg Health, Framingham, MA Dr. Brian Berman is Professor Emeritus of Dermatology and Dermatologic Surgery at The University of Miami Miller School of Medicine and has had the honor of serving as a member of the Board of Directors and Vice President of the American Academy of Dermatology. He is Past President of the American Dermatological Association. Dr. Berman is Secretary of the American Cutaneous Oncology Society, Secretary of the American Hyperhidrosis Medical Society, past President and the Founder of The National Association of Veterans Affairs Dermatologists, and serves on the Scientific Advisory / Editorial Boards of The European Journal of Dermatology, SKINmed, Journal of Clinical and Aesthetic Dermatology, Dermatology Digest, and SKIN, and edited The Miami Review series. In addition to caring for patients at Skin and Cancer Associates in Aventura, FL, Dr. Berman is Co-Director of the Center for Clinical and Cosmetic Research, continuing his broad-based clinical research program while focusing on the study of the control of scarring and skin cancer. He has presented at over 300 local, regional, state, national and international dermatologic societies and conferences and authored of more than 250 peer-reviewed scientific and clinical articles, chapters and books. In 2021 the Florida Society of Dermatology and Dermatologic Surgery recognized Dr. Berman as “Practitioner of the Year.” D. Berman serves as Senior Scientific Advisor and Acting Chief Medical Officer at Berg Health, a clinical-stage, AI-powered biotechnology company. PS Home

Lawrence Schachner, MD < Back Lawrence Schachner, MD Faculty Bio coming soon. PS Home

Aaron Farberg, MD < Back Aaron Farberg, MD Faculty Aaron S. Farberg, M.D. is a double board-certified dermatologist and fellowship-trained Mohs surgeon that specializes in skin cancer, inflammatory diseases, and cosmetic dermatology. Dr. Farberg is a summa cum laude graduate of Emory University and continued his education at the University of Michigan, where he received his medical degree. Dr. Farberg’s post-graduate training includes additional residency years at the University of Michigan in Plastic and Reconstructive Surgery and, in New York, as a clinical research fellow in association with the National Society for Cutaneous Medicine and New York University. He then remained in New York, completing another residency in Dermatology at the Icahn School of Medicine at Mount Sinai Hospital, where he served as chief resident. In addition to treating patients, Dr. Farberg has been a clinical investigator on numerous studies, including FDA clinical trials. He is an accomplished author and has published over 100 articles in professional medical journals. He serves as a member of the editorial board for several medical journals including Dermatology & Therapy and SKIN. Dr. Farberg also founded the Dermatology Science and Research Foundation to provide dermatology education to his patients and peers. Dr. Farberg has been recognized as one of Dallas’s leading dermatologists with numerous awards and honors. He most recently was ranked by his dermatology colleagues in Newsweek Magazine as the #1 medical dermatologist in Texas and #6 in the entire country. While in New York he served as a consultant dermatologist for the New York Yankees. Hone Home